World AIDS Day
1 December 2022
World AIDS Day is held on 1 December each year. It raises awareness across the world and in the community about HIV and AIDS. It is a day for the community to show their support for people living with HIV and to commemorate people who have died of AIDS related conditions or other conditions associated with HIV. World Aids Day _________________________________________________________________________________
UpToDate
Diagnosis
Prevention
Treatment
Articles
Journal
E-books
________________________________________________________________________________
Articles
A retrospective cohort study of women and men living with HIV, attending an HIV clinic in Australia Women health reports 9 November 2022
In this study of 170 people living with HIV, nearly one-half of the men with known HIV history were diagnosed through sexual health screens, but women's HIV was mostly detected through targeted screening. Results highlight gender disparity in access to sexual health screening and assessment, including low awareness of sexual health risks for women, and endorse the view that HIV is a heterosexual sexually transmittable infection in women.
Stigma regarding HIV and sexual identity as barriers to accessing HIV testing and prevention services among gay and bisexual migrants in Australia Sexuality research and social policy 28 October 2022
Addressing these multifaceted HIV testing and prevention barriers requires policies, systems, and interventions that increase health literacy about HIV testing, prevention, and treatment; build trust and confidence when navigating Australian health services; and reduce the impacts of HIV and sexual identity stigmas in migrants’ countries of origin on their experiences in Australia.
Australian sexually transmitted infection (STI) management guidelines for use in primary care 2022 update Sexual health 11 November 2022
The ‘Australian Sexually Transmitted Infection (STI) Management Guidelines For Use In Primary Care’ (www.sti.guidelines.org.au) provide evidence-based, up-to-date guidance targeted at use in primary care settings. A major review of the guidelines was undertaken in 2020–22. All content was reviewed and updated by a multi-disciplinary group of clinical and non-clinical experts, and assessed for appropriateness of recommendations for key affected populations and organisational and jurisdictional suitability. The guidelines are divided into six main sections: (1) standard asymptomatic check-up; (2) sexual history; (3) contact tracing; (4) STIs and infections associated with sex; (5) STI syndromes; and (6) populations and situations. This paper highlights important aspects of the guidelines and provides the rationale for significant changes made during this major review process.
Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review HIV medicine 15 July 2022
These findings suggest that people living with HIV (PLHIV) with well-controlled disease are not at risk of poorer COVID-19 disease outcomes than the general population. It is not clear whether those with poorly controlled HIV disease and AIDS have poorer outcomes. Superimposed bacterial pneumonia may be a risk factor for more severe COVID-19 but further research is urgently needed to elucidate whether PLHIV are more at risk than the general population.
Suicidality among people living with HIV From 2010 to 2021: A systematic review and a meta-regression Psychosomatic Medicine 6 September 2022
The risk of suicidality is high among PLHIV within all six World Health Organization regions during the modern antiretroviral therapy era. Assessment of socioeconomic and psychological factors is recommended for further management to prevent suicide among PLHIV. The present findings are useful for design of intervention protocols and development of clinical practice guidelines intended to manage the well-being of PLHIV worldwide.
The acceptability and usability of two HIV self‐test kits among men who have sex with men: a randomised crossover trial MJA 18 July 2022
It is important to provide options for obtaining both oral fluid‐ and blood‐based HIV self‐tests. The usability and acceptability of both kits were high, but the ease of use and perceived accuracy influenced test kit preference.
Factors associated with willingness to use daily antibiotics as STI prophylaxis among HIV-PrEP-experienced gay and bisexual men in Australia Sexuality transmitted diseases 8 November 2022
Pexually transmitted infections - pre-exposure prophylaxis STI-PrEP is likely to be appealing to many HIV-PrEP-experienced Gay and bisexual men (GBM), especially those who engage in activities associated with higher risk of STI transmission. However, they are less likely to be willing to use STI-PrEP unless it aligns with their HIV-PrEP dosing regimen, suggesting that research into the safety and efficacy of alternative STI prophylaxis dosing options should be prioritised.
Comparing the effects of HIV self-testing to standard HIV testing for key populations: a systematic review and meta-analysis BMC medicine 3 December 2020
HIV self-testing (HIVST) is safe and increases testing uptake and frequency as well as yield of positive results for men who have sex with men (MSM) and trans people without negative effects on linkage to HIV care, STI testing, condom use or social harm. Testing uptake was increased for FSW, yield of positive results were not and linkage to HIV care was worse. Strategies to improve linkage to care outcomes for both groups are crucial for effective roll-out.
_________________________________________________________________________________
This is just a sample of the journals the library subscribes to – you will need your library login
_________________________________________________________________________________
This is just a sample of the e-books the library subscribes to – you will need your library login
_________________________________________________________________________________
Missed out on a previous awareness week? You can now see previous awareness weeks here.
